|
Marshall E. Reese Ph.D is executive vice president product development.
Dr. Reese is responsible for overseeing all of the company’s product development activities. Most recently Dr. Reese was at the Swiss-based pharmaceutical company Novartis as senior vice president and global head of research and development Consumer Health Care. Prior to joining Novartis in 1999 Dr. Reese held several senior executive positions over 16 years at Glaxo Inc. and GlaxoWellcome including vice president of global OTC development and manufacturing with GlaxoWellcome based in the United States and vice president of development planning and international OTC strategies for Glaxo and GlaxoWellcome in both the United States and the United Kingdom.
During his tenures with Glaxo and Novartis Dr. Reese was responsible for managing the switch from prescription to over-the-counter medications for Lamisil topical Voltaren oral topical and patches and Nicotine gum lozenge and patches in Europe Middle East Africa and Japan and for Beconase AQ Zovirax and Zantac 75 in Europe. Additionally he managed the regulatory approval process for Augmentin Beconase AQ Ventolin Rotocaps and Ventolin Syrup in the United States.
Dr. Reese received his B.S. M.S. and Ph.D. degrees from the University of Tennessee at Knoxville. | 